Page last updated: 2024-09-03

c 1311 and Neutropenia

c 1311 has been researched along with Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourbouloux, E; Campone, M; Capizzi, R; Drouin, M; Fumoleau, P; Grieshaber, C; Isambert, N; Loadman, P; Major, A; Yin, W	1

Trials

1 trial(s) available for c 1311 and Neutropenia

Article	Year
Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:4 Topics: Administration, Oral; Adult; Aged; Aminoacridines; Antineoplastic Agents; Biological Availability; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome	2010

Article

Year

Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours.

European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:4

Topics: Administration, Oral; Adult; Aged; Aminoacridines; Antineoplastic Agents; Biological Availability; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome

2010